{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-035171","form_type":"8-K","ticker":"AGL","cik":"0001831097","company_name":"agilon health, inc.","filed_at":"2024-08-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.770687+00:00","generated_at":"2026-05-31T12:34:51.136289+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"agilon health Q2 revenue up 39% to $1.48B but net loss widens to $31M","bullets":["Revenue $1.48B (+39% YoY); MA membership 513K (+38%).","Net loss $31M vs $17M loss year ago; gross profit fell to $32M from $55M.","Medical margin $106M (down 21% YoY); Adjusted EBITDA loss $3M vs $12M gain.","Retroactive termination of unprofitable contracts cut membership by 17K and revenue by $110M.","Maintains FY2024 medical margin ($400-450M) and Adjusted EBITDA (-$60 to -$15M) guidance."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-035171","json":"https://secwatch.observer/filing/0001628280-24-035171.json","markdown":"https://secwatch.observer/filing/0001628280-24-035171.md","text":"https://secwatch.observer/filing/0001628280-24-035171.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1831097/000162828024035171/0001628280-24-035171-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1831097/000162828024035171/agl-20240806.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T12:34:51.136289+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}